MedPath

Randomised Control Trial To Compare Central Macular Thickness(Retinal thickness) in Patients Undergoing Phacoemulsification(Phaco Cataract surgery) with or without Intravitreal Dexamethasone(steroid) Injection in Patients with Coexisting Diabetic Macular Edema(fluid in retina due to Diabetes)

Phase 3
Conditions
Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
Registration Number
CTRI/2024/05/068093
Lead Sponsor
orthern Railway Central Hopital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Type 1 and 2 Diabetes Mellitus.

2.Visual Acuity of 6/12 or less.

3.Central macular thickness of 300 microns or less.

4.Any gender.

Exclusion Criteria

1 Any co-existing retinal pathology apart from diabetic retinopathy likely to affect visual acuity.

2 Vitrectomised Eye.

3 Uncontrolled Diabetes defined of HbA1c more than 10 percent.

4 Any intra operative or post-operative complication effecting the visual acuity.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath